Procurement Summary
Country : USA
Summary : Bruton Tyrosine Kinase (Btk) Inhibitors (Va-24-00023127)
Deadline : 22 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95766167
Document Ref. No. : 36E79724R0007
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Pre-solicitation NoticeThe VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0007 for an unrestricted procurement for Bruton Tyrosine Kinase (BTK) Inhibitors for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC or UPC number that is unique to the offeror. Solicitation # 36E79724R0007 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 8, 2024, with a tentative closing date of February 22, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Ray Roldan. Questions can be e-mailed to: Raymond.roldan@va.gov. The estimated annual requirements are as follows: ItemDescriptionUnits (Tablets or Capsules) per DayTotal For New Patients1AIbrutinib Capsules 140MG32, 444OROROROR1BAcalabrutinib Tablets 100MG22, 444OROROROR1CZanubrutinib Capsules 80MG42, 444The price evaluation will be completed by multiplying the proposed BTK Inhibitors price by the number of units per day required per pati...
Active Contract Opportunity Notice ID 36E79724R0007 Related Notice Department/Ind. Agency VETERANS AFFAIRS, DEPARTMENT OF Sub-tier VETERANS AFFAIRS, DEPARTMENT OF Office NAC PHARMACEUTICALS (36E797)
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-06:00) CENTRAL STANDARD TIME, CHICAGO, USA
Original Published Date: Jan 24, 2024 03:47 pm CST
Original Response Date: Feb 22, 2024 02:30 pm CST
Inactive Policy: Manual
Original Inactive Date: May 31, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:,
Documents
Tender Notice
36E79724R0007_1.docx